Damora Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Damora Therapeutics, Inc. (GLTO) is 800.32M

According to Damora Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 800.32M. This represents a change of 169.99% compared to the average of 296.43M of the last 4 quarters.

Damora Therapeutics, Inc. (GLTO) Historical Enterprise Value (quarterly & annually)

How has GLTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Damora Therapeutics, Inc. over the last ten years is 81.36M. The current 800.32M Enterprise Value has changed 883.71% with respect to the historical average. Over the past ten years (40 quarters), GLTO's Enterprise Value was at its highest in in the June 2026 quarter at 1.05B. The Enterprise Value was at its lowest in in the December 2025 quarter at -219415337.31.

Damora Therapeutics, Inc. (GLTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Damora Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Damora Therapeutics, Inc. (GLTO) Average Enterprise Value

How has GLTO Enterprise Value performed in the past?

The current Enterprise Value of Damora Therapeutics, Inc. (GLTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Damora Therapeutics, Inc. (GLTO) Enterprise Value vs. Peers

How is GLTO’s Enterprise Value compared to its peers?

Damora Therapeutics, Inc.’s Enterprise Value is greater than TransCode Therapeutics, Inc. (-5965226.00), greater than Phio Pharmaceuticals Corp. (-2581135.00), greater than Aprea Therapeutics, Inc. (-34939137.00), greater than Kiora Pharmaceuticals, Inc. (1.42M), greater than IN8bio, Inc. (-6207499.00), greater than Acurx Pharmaceuticals, Inc. (-4707824.00), greater than Aptevo Therapeutics Inc. (-253410.71), greater than Lyra Therapeutics, Inc. (14.42M), less than Adial Pharmaceuticals, Inc. (0), greater than BioCardia, Inc. (9.86M),

Build a custom stock screener for Damora Therapeutics, Inc. (GLTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Damora Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Damora Therapeutics, Inc. (GLTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Damora Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.